Rolling Out7d
Why COPD affects women differently
The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
pulmonologyadvisor12d
Benralizumab Improves Eosinophilic Exacerbations in Asthma, COPD
Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
Oral Syringes Industry Eyes $1.05 Billion Opportunity by 2030: Baxter, BD, Medtronic, Terumo Medical Corp, and Braun Lead the Competition
The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...
PR Newswire10d
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
Additional clinical trials are planned in asthma and chronic obstructive pulmonary disease (COPD ... with a dosing regimen of every six months, which can reduce the burden of treatment and ...
Medscape3d
High Dose N--Acetylcysteine in Patients With Exacerbations of Chronic Obstructive Pulmonary Disease
Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...
News Medical on MSN1h
Researchers create an atlas of health associations for GLP-1 receptor agonists
Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...